Pfizer is jointly marketing the drug Eliquis.
2 reports, 2 independent
Updated Sep 10
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer is jointly marketing the drug Eliquis.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Pricing reversals pose a key risk to Eliquis's market share.1 source
Pfizer is jointly marketing the drug Eliquis.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Bristol-Myers Squibb
American pharmaceutical company
Related events
- FDA and Pfizer are seeking regulatory approval for their products.
- A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
- Pfizer's performance is being analyzed in comparison to the broader market.
- Pfizer and Nexentis Technologies, both healthcare companies, are competing for investment, with Pfizer reporting higher revenue and earnings.